Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Feb 5, 2021	EFFECT	EFFECT	View HTML 9999999995-21-000476.pdf 9999999995-21-000476.rtf 9999999995-21-000476.xls
Feb 3, 2021	UPLOAD	UPLOAD	View HTML 0000000000-21-001369.pdf 0000000000-21-001369.rtf
Feb 3, 2021	CORRESP	CORRESP	View HTML 0000320017-21-000014.pdf 0000320017-21-000014.rtf
Feb 1, 2021	D	Notice of Exempt Offering of Securities	View HTML 0000320017-21-000010.pdf 0000320017-21-000010.rtf 0000320017-21-000010.xls
Jan 29, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-21-000009.pdf 0000320017-21-000009.rtf 0000320017-21-000009.xls
Jan 29, 2021	S-3	Simplified registration form	View HTML 0001104659-21-009368.pdf 0001104659-21-009368.rtf 0001104659-21-009368.xls
Jan 25, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-21-000006.pdf 0000320017-21-000006.rtf 0000320017-21-000006.xls
Jan 15, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001334549-21-000005.pdf 0001334549-21-000005.rtf 0001334549-21-000005.xls
Jan 12, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001284500-21-000003.pdf 0001284500-21-000003.rtf 0001284500-21-000003.xls
Jan 12, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001593283-21-000005.pdf 0001593283-21-000005.rtf 0001593283-21-000005.xls